Consultation on the draft Pharmaceutical Needs Assessment for Hampshire 2022

Closed on
Decided on

Hampshire Health and Wellbeing Board is under a statutory obligation to develop, consult upon and update a pharmaceutical needs assessment (PNA)

Section 126 of the 2006 Act places an obligation on NHS England and NHS Improvement to put arrangements in place so that drugs, medicines and listed appliances ordered via NHS prescriptions can be supplied to persons. The Community Pharmacy Contractual Framework (CPCF) for 2019/20 to 2023/24 was agreed by the Department of Health and Social Care (DHSC), NHS England and the Pharmaceutical Services Negotiating Committee (PSNC) and describes a joint vision for how community pharmacy will support delivery of the NHS Long Term Plan.

Pharmaceutical services is a collective term for a range of services commissioned by NHS England. In relation to PNAs it includes:

  • Essential services
  • Advanced services
  • Enhanced services
  • Local pharmaceutical services (LPS) contracts that are the equivalent of essential, advanced and enhanced services.

The purpose of the PNA is to assess and set how the provision of pharmaceutical services can meet the current and future health needs of the population of Hampshire for a period of up to three years. The document is then used by NHS England as the basis for determining market entry to a pharmaceutical list including the opening of additional pharmacies, relocations of premises and amendments to opening hours or pharmaceutical services.

The consultation was open from 4 April 2022 and closed at 11.59pm on 5June 2022.

The Health and Wellbeing Board is required to consult a specified range of relevant organisations on a draft of the PNA at least once during the process of developing the document. This consultation was also open to members of the public. Your feedback will be used to inform further development of the PNA which was published in October this year.

Key documents

Hampshire’s draft PNA 2022
Needs Appendix
Locality Appendix

The findings of this consultation have now been published.

The Hampshire Pharmaceutical Needs Assessment 2022-25